Lumibird SA (EPA:LBIRD)
France · Delayed Price · Currency is EUR 19.40
+0.10 (0.52%)
At close: Nov 28, 2025
Lumibird Market Cap
Lumibird has a market cap or net worth of €427.22 million as of November 28, 2025. Its market cap has increased by 168.23% in one year.
Market Cap
427.22M
Enterprise Value
521.68M
Revenue
219.10M
Ranking
n/a
PE Ratio
39.83
Stock Price
€19.40
Market Cap Chart
Since July 25, 2018, Lumibird's market cap has increased from 230.33M to 427.22M, an increase of 85.48%. That is a compound annual growth rate of 8.77%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 28, 2025 | 427.22M | 107.48% |
| Dec 31, 2024 | 205.91M | -23.62% |
| Dec 29, 2023 | 269.59M | -27.13% |
| Dec 30, 2022 | 369.94M | -30.68% |
| Dec 31, 2021 | 533.70M | 70.71% |
| Dec 31, 2020 | 312.64M | 11.73% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Jul 25, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| EssilorLuxottica Société anonyme | 142.36B |
| Sanofi | 104.35B |
| Sartorius Stedim Biotech | 20.17B |
| bioMérieux | 12.74B |
| Eurofins Scientific SE | 10.39B |
| Ipsen | 10.21B |
| ABIVAX Société Anonyme | 8.16B |
| Virbac | 3.08B |